You just read:

European Investment Bank (EIB) Supports Late-Stage Development and Production of BiondVax's Universal Flu Vaccine Candidate Under Horizon 2020 Initiative

News provided by

BiondVax Pharmaceuticals Ltd.

Jun 19, 2017, 07:00 ET